Evidence map›Paper›PMID 28105203›Full record

ArticleOncology letters2016

Polyphyllin I inhibits the growth of ovarian cancer cells in nude mice.

Linhui Gu, Jianguo Feng, Zhiguo Zheng, Haiyan Xu, Wei Yu

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Linhui GuResearch Institute, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China; Key Laboratory of Diagnosis and Treatment Technology on Thoracic Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Jianguo FengResearch Institute, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China; Key Laboratory of Diagnosis and Treatment Technology on Thoracic Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Zhiguo ZhengResearch Institute, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China; Key Laboratory of Diagnosis and Treatment Technology on Thoracic Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Haiyan XuBiological Specimen Bank, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Wei YuBiological Specimen Bank, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China.
Zhejiang Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polyphyllin I (PPI) is an active component in Rhizoma Paridis, which displays extensive pharmacological antitumor activities. In a previous study, we found that polyphyllin I exhibited inhibitory effects on cell growth in the human ovarian cancer HO-8910PM cell line, as well as promoting apoptosis and the inhibition of cell migration. Furthermore, gene expression was also profiled by microarray, which showed that numerous genes were altered by PPI; three genes were of particular note that were associated with tumor progression, namely, Caspase-9, C-jun and Wnt5a. In the present study, the effect of PPI on subcutaneous tumor growth (HO-8910PM cells) in nude mice was further evaluated, and immunohistochemistry and reverse transcription polymerase chain reaction (RT-PCR) were used to examine the expression of Caspase-9, C-jun and Wnt5a in subcutaneous and lung metastatic tumor tissues, in order to investigate the possible mechanisms involved. The results showed that PPI significantly inhibited the tumor growth

Indexed as

Caspase-9C-jungrowthovarian cancerpolyphyllin IWnt5a

Identifiers

PMID28105203
PMCPMC5228467
OpenAlexW2546669315

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.